News, Short Squeeze, Breakout and More Instantly...
Biodexa Pharmaceuticals PLC-ADR Company Name:
BDRX Stock Symbol:
NASDAQ Market:
Biodexa Pharmaceuticals PLC-ADR Website:
July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024 After Only Two Infusions and Two Patients at Optimal Dose, Median Overall Survival Across all Patients was 16....
June 24, 2024 Biodexa Pharmaceuticals PLC Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP) Overall 75% Non-progression Rate at 12 Months Median Decrease in Overall Polyp Burden at 12 Month...
13 June 2024 Biodexa Pharmaceuticals PLC (“ Biodexa ” or the “ Company ”) Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline...